§ Funding Round
SAB Biotherapeutics raised $22M Series A venture round.
This funding round does not have an about section yet.
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$37.4M
Top Valuation
-
SAB Biotherapeutics raised $22M in a Series A round.
The round was announced on 12/20/18.
